Mark Alan Goldberg - Dec 29, 2023 Form 4 Insider Report for ImmunoGen, Inc. (IMGN)

Role
Director
Signature
/s/ Renee Lentini, Attorney-in-Fact
Stock symbol
IMGN
Transactions as of
Dec 29, 2023
Transactions value $
$16,871
Form type
4
Date filed
1/3/2024, 05:45 PM
Previous filing
Nov 1, 2023
Next filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Award $16.9K +569 +0.95% $29.65 60.7K Dec 29, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of common stock issued pursuant to the Compensation Policy for Non-Employee Directors as amended June 14, 2023 in lieu of cash compensation for services performed for the quarter ended December 31, 2023.